Evaluation of Association Methods for Analysing Modifiers of Disease Risk in Carriers of High‐Risk Mutations
- 24 April 2012
- journal article
- research article
- Published by Wiley in Genetic Epidemiology
- Vol. 36 (3) , 274-291
Abstract
There is considerable evidence indicating that disease risk in carriers of high‐risk mutations (e.g. BRCA1 and BRCA2) varies by other genetic factors. Such mutations tend to be rare in the population and studies of genetic modifiers of risk have focused on sampling mutation carriers through clinical genetics centres. Genetic testing targets affected individuals from high‐risk families, making ascertainment of mutation carriers non‐random with respect to disease phenotype. Standard analytical methods can lead to biased estimates of associations. Methods proposed to address this problem include a weighted‐cohort (WC) and retrospective likelihood (RL) approach. Their performance has not been evaluated systematically. We evaluate these methods by simulation and extend the RL to analysing associations of two diseases simultaneously (competing risks RL—CRRL). The standard cohort approach (Cox regression) yielded the most biased risk ratio (RR) estimates (relative bias—RB: −25% to −17%) and had the lowest power. The WC and RL approaches provided similar RR estimates, were least biased (RB: −2.6% to 2.5%), and had the lowest mean‐squared errors. The RL method generally had more power than WC. When analysing associations with two diseases, ignoring a potential association with one disease leads to inflated type I errors for inferences with respect to the second disease and biased RR estimates. The CRRL generally gave unbiased RR estimates for both disease risks and had correct nominal type I errors. These methods are illustrated by analyses of genetic modifiers of breast and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.Keywords
This publication has 29 references indexed in Scilit:
- Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriersHuman Molecular Genetics, 2009
- A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2Nature Genetics, 2009
- Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1Nature Genetics, 2009
- The Average Cumulative Risks of Breast and Ovarian Cancer for Carriers of Mutations in BRCA1 and BRCA2 Attending Genetic Counseling Units in SpainClinical Cancer Research, 2008
- Variation of Breast Cancer Risk Among BRCA1/2 CarriersJAMA, 2008
- RAD51 135G→C Modifies Breast Cancer Risk among BRCA2 Mutation Carriers: Results from a Combined Analysis of 19 StudiesThe American Journal of Human Genetics, 2007
- Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 StudiesThe American Journal of Human Genetics, 2003
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesThe American Journal of Human Genetics, 1998
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997